QA: Anixa Biosciences Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000715446_2026_Anixa_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0000715446, Anixa Biosciences Inc

  xvar xval
0 AssetsCurrent 15,887,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 193,000
4 LiabilitiesCurrent 1,967,000
5 LiabilitiesNoncurrent 163,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,807,389
9 ResearchAndDevelopmentExpense 5,220,350
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 826,835
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 16,080,000
1 Liabilities 2,130,000
2 Expenses 12,027,739
3 Revenues 0
4 StockholdersEquity 13,950,000
5 NetIncome -11,200,904
6 ComprehensiveNetIncome -11,200,904
7 BaseVar 15,532,287
8 EconomicCapitalRatiobeforeLimitedLiability 2.11
9 EconomicCapitalRatio 3.10

Edgar->Model Mapping

Feature Distribution

Change over Time